TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-29
Latest data update time: Updated on 2026-03-29
6.20 / 10Overall Score
OutperformInvestment Rating
6.20 / 10Overall Score
OutperformInvestment Rating
Is TRDA a Good Buy Right Now?
- Based on a composite score of 6.20/10, we rate TRDA as a Outperform. Our analysis breaks down into 7.24/10 for Fundamentals, 3.91/10 for Technicals, and 6.81/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of TRDA?
Is TRDA undervalued or overvalued?
What is the analyst consensus for TRDA?
Is TRDA a Good Buy Right Now?
- Based on a composite score of 6.20/10, we rate TRDA as a Outperform. Our analysis breaks down into 7.24/10 for Fundamentals, 3.91/10 for Technicals, and 6.81/10 for Sentiment, indicating the stock is likely to See further upside.
Is TRDA undervalued or overvalued?
Technical Analysis of TRDA?
What is the analyst consensus for TRDA?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
